RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS
肥胖 Zucker 大鼠肾多巴胺受体功能
基本信息
- 批准号:6517840
- 负责人:
- 金额:$ 21.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-01 至 2005-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from the application): Dopamine and D1-like receptors in
the proximal tubules and other regions of the nephron play an important role in
regulating renal sodium excretion. A defective DIA receptor (a D1-like
receptor) function is reported in the proximal tubules of hepertensive animals
and humans. In our preliminary studies we found that D1-Iike receptors are
reduced by 50 percent and dopamine was unable to stimulate second messengers
(cAMP and IP3) and thereby failed to inhibit Na,K-ATPase and Na,H-exchanger in
the proximal tubules of obese Zucker rats (12 week old).
Therefore, it is hypothesized that the diminished inhibitory effect of dopamine
on sodium transporting proteins in the proximal tubules is due to a dysfunction
in DIA receptor which results from altered phosphorylation of membranal DIA
receptor as well as impaired recruitment of newer D1A receptors from cytosol.
Such a defect in dopamine receptor function contributes to the diminished
natriuretic response to exogenously administered as well as endogenously
produced dopamine. This hypothesis will be tested by conducting a series of
experiments to identify the biochemical/molecular mechanism(s) contributing
towards the defect in DIA receptors. These will include: measurement of D1A
receptor agonist affinity, determination of the effect of GTPyS on ligand
binding, determination of agonist-dependent and -independent phosphorylation of
D1A receptor, determination of agonist recmitment of D1A receptors on the
membrane and measurement of D1A receptor mRNA and DIA receptor protein content
in proximal tubules of lean and obese rats. The functional consequence of the
defective DIA receptor function will be examined by studying the natriuretic
and diuretic effect of dopamine and SKF38393 as well as by determining the
effect of acute volume expansion on renal production of dopamine and sodium and
water excretion in anesthetized lean and obese Zucker rats. In order to
delineate the role of hyperinsulinemia in causing the defective D1A receptor
function and the natriuretic response, experiments described above will also be
performed in lean and obese rats (7-8 weeks) treated for four weeks with
darglitazone, a drug which decreases insulin levels and improve insulin
sensitivity as well as in 3-4 week old non-treated hyperinsulinemic and control
rats. Identification of the mechanism(s) leading to dopamine receptor
dysfunction and the diminished natriuretic response to dopamine would allow us
to better understand the relationship between kidney D1A receptor function and
hyperinsulinemia in obese rats.
描述(来自申请的逐字):多巴胺和D1样受体,
肾单位的近端小管和其它区域在
调节肾钠排泄。缺陷性DIA受体(D1样
受体)功能的报道,在近端小管的高血压动物
还有人类在我们的初步研究中,我们发现D1样受体
减少了50%,多巴胺无法刺激第二信使,
(cAMP和IP 3),从而未能抑制Na,K-ATP酶和Na,H-交换,
肥胖Zucker大鼠(12周龄)的近端小管。
因此,可以假设多巴胺的抑制作用减弱
对近端小管中钠转运蛋白的影响是由于
在DIA受体中,其由膜DIA的磷酸化改变引起
受体以及受损的招聘较新的D1 A受体从胞质溶胶。
多巴胺受体功能的这种缺陷有助于减少
对外源性和内源性给药的利钠反应
产生多巴胺。这一假设将通过进行一系列
实验以确定生物化学/分子机制,
针对DIA受体的缺陷。这些将包括:D1 A的测量
受体激动剂亲和力,测定GTP γ S对配体的作用
结合,激动剂依赖性和非依赖性磷酸化的测定
D1 A受体,D1 A受体激动剂的测定
膜和D1 A受体mRNA和DIA受体蛋白含量的测量
在瘦和肥胖大鼠的近端小管中。的功能后果
DIA受体功能缺陷将通过研究尿钠排泄来检查。
多巴胺和SKF 38393的利尿作用以及通过测定
急性扩容对肾脏多巴胺和钠产生影响
在麻醉的瘦和肥胖Zucker大鼠中的水排泄。为了
描述高胰岛素血症在导致D1 A受体缺陷中的作用
功能和利钠反应,上述实验也将
在瘦和肥胖大鼠(7-8周)中进行,用
达格列酮,一种降低胰岛素水平和改善胰岛素分泌的药物,
敏感性以及3-4周龄未治疗高胰岛素血症和对照
大鼠确定导致多巴胺受体的机制
功能障碍和对多巴胺的利钠反应减弱
为了更好地了解肾脏D1 A受体功能与
高胰岛素血症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mustafa F. Lokhandwala其他文献
Influence of Felodipine and Verapamil on the Sympathetic Transmitter Release and on the Pre- and Post-Junctional Effects of Exogenous Noradrenaline in the Perfused Rat Kidney
- DOI:
10.2165/00003495-198500292-00035 - 发表时间:
1985-01-01 - 期刊:
- 影响因子:14.400
- 作者:
Eno J. Peter;Marie L. Steenberg;Mustafa F. Lokhandwala;Bhagavan S. Jandhyala;Douglas C. Eikenburg - 通讯作者:
Douglas C. Eikenburg
Reviews: Beta‐blockers‐Present status and future prospects. Edited by W. Schweizer. University Park Press, Chamber of Commerce Building, Baltimore, MD 21202,1974.325 pp. 17.5 × 24.5 cm. Price $19.50.
- DOI:
10.1002/jps.2600651144 - 发表时间:
1976-11-01 - 期刊:
- 影响因子:
- 作者:
Mustafa F. Lokhandwala - 通讯作者:
Mustafa F. Lokhandwala
Central α-Adrenergic Control of Blood Pressure: Effects of Clonidine Withdrawal
- DOI:
10.1378/chest.83.2.328 - 发表时间:
1983-02-01 - 期刊:
- 影响因子:
- 作者:
Steven J. Augustine;Shiro Tachikawa;Mustafa F. Lokhandwala;Joseph P. Buckley - 通讯作者:
Joseph P. Buckley
Central α-Adrenergic Control of Blood Pressure: Effects of Clonidine Withdrawal
- DOI:
10.1378/chest.83.2_supplement.328 - 发表时间:
1983-02-01 - 期刊:
- 影响因子:
- 作者:
Steven J. Augustine;Shiro Tachikawa;Mustafa F. Lokhandwala;Joseph P. Buckley - 通讯作者:
Joseph P. Buckley
Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and β2 adrenoceptor agonist
- DOI:
10.1007/bf00175033 - 发表时间:
1994-09-01 - 期刊:
- 影响因子:3.100
- 作者:
Severina M. Jacinto;Mustafa F. Lokhandwala;Bhagavan S. Jandhyala - 通讯作者:
Bhagavan S. Jandhyala
Mustafa F. Lokhandwala的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mustafa F. Lokhandwala', 18)}}的其他基金
Transcriptional regulation of renal dopamine D1 receptors in hypertension during
高血压期间肾脏多巴胺 D1 受体的转录调控
- 批准号:
8881163 - 财政年份:2013
- 资助金额:
$ 21.02万 - 项目类别:
Transcriptional regulation: renal dopamine D1 receptors in HTN & oxidative stress
转录调控:HTN 中的肾多巴胺 D1 受体
- 批准号:
8577204 - 财政年份:2013
- 资助金额:
$ 21.02万 - 项目类别:
Transcriptional regulation of renal dopamine D1 receptors in hypertension during
高血压期间肾脏多巴胺 D1 受体的转录调控
- 批准号:
9098451 - 财政年份:2013
- 资助金额:
$ 21.02万 - 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
- 批准号:
7473941 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
- 批准号:
7097261 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
- 批准号:
7257008 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
- 批准号:
6980346 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
- 批准号:
7656746 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS
肥胖 Zucker 大鼠肾多巴胺受体功能
- 批准号:
6230924 - 财政年份:2001
- 资助金额:
$ 21.02万 - 项目类别:
RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS
肥胖 Zucker 大鼠肾多巴胺受体功能
- 批准号:
6707999 - 财政年份:2001
- 资助金额:
$ 21.02万 - 项目类别:
相似国自然基金
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
- 批准号:82171969
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
- 批准号:82060323
- 批准年份:2020
- 资助金额:34 万元
- 项目类别:地区科学基金项目
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
- 批准号:81460271
- 批准年份:2014
- 资助金额:46.0 万元
- 项目类别:地区科学基金项目
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
- 批准号:81060019
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
相似海外基金
EFFECT OF DOPAMINE AGONISTS ON PLASMA AMINO ACIDS
多巴胺激动剂对血浆氨基酸的影响
- 批准号:
7203395 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
- 批准号:
7180899 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
- 批准号:
6976586 - 财政年份:2004
- 资助金额:
$ 21.02万 - 项目类别:
Inhaled dopamine agonists for late stage Parkinsonism
吸入多巴胺激动剂治疗晚期帕金森病
- 批准号:
6792448 - 财政年份:2003
- 资助金额:
$ 21.02万 - 项目类别:
Inhaled dopamine agonists for late stage Parkinsonism
吸入多巴胺激动剂治疗晚期帕金森病
- 批准号:
6914942 - 财政年份:2003
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
- 批准号:
6379037 - 财政年份:2000
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
- 批准号:
6310834 - 财政年份:2000
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
- 批准号:
6120219 - 财政年份:1999
- 资助金额:
$ 21.02万 - 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
- 批准号:
6016930 - 财政年份:1999
- 资助金额:
$ 21.02万 - 项目类别: